Literature DB >> 6688376

Local administration of interferon for malignant brain tumors.

Y Nakagawa, K Hirakawa, S Ueda, K Suzuki, S Fukuma, T Kishida, J Imanishi, T Amagai.   

Abstract

We investigated the effects of local administration of interferon (IFN) on 13 patients with recurrent brain tumors. Histologic diagnoses were glioblastoma (eight patients), medulloblastoma (one), ependymoma (one), ependymoblastoma (one), pontine glioma (one), and astrocytoma (one). When tumor recurrence was evident local administration of IFN was started through an Ommaya reservoir, which was placed during repeat craniotomy. No tumor regressions were seen in the patients given weekly injections of IFN; however, in two of six patients given daily injections, a decrease of tumor volume and augmentation of natural killer activity were seen.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6688376

Source DB:  PubMed          Journal:  Cancer Treat Rep        ISSN: 0361-5960


  12 in total

Review 1.  Neuro-oncology index and review (adult primary brain tumors). Radiotherapy, chemotherapy, immunotherapy, photodynamic therapy.

Authors:  M S Mahaley
Journal:  J Neurooncol       Date:  1991-10       Impact factor: 4.130

2.  A pilot study of recombinant interferon beta (IFN-beta ser) in patients with recurrent glioma.

Authors:  W K Yung; A M Castellanos; P Van Tassel; R P Moser; S G Marcus
Journal:  J Neurooncol       Date:  1990-08       Impact factor: 4.130

3.  Growth inhibitory effect of recombinant alpha and beta interferon on human glioma cells.

Authors:  W K Yung; P A Steck; P J Kelleher; R P Moser; M G Rosenblum
Journal:  J Neurooncol       Date:  1987       Impact factor: 4.130

Review 4.  Cytokine networks in glioma.

Authors:  Kenichiro Iwami; Atsushi Natsume; Toshihiko Wakabayashi
Journal:  Neurosurg Rev       Date:  2011-06-09       Impact factor: 3.042

5.  Phase I clinical trial of intralesional or intraventricular leukocyte interferon for intracranial malignancies.

Authors:  E A Obbens; L G Feun; M E Leavens; N Savaraj; D J Stewart; J U Gutterman
Journal:  J Neurooncol       Date:  1985       Impact factor: 4.130

6.  The effects of local and systemic interferon beta (Fiblaferon) on supratentorial malignant cerebral glioma--a phase II study.

Authors:  K R von Wild; T H Knocke
Journal:  Neurosurg Rev       Date:  1991       Impact factor: 3.042

7.  Sensitivities of human glioma cell lines to interferons and double-stranded RNAs individually and in synergistic combinations.

Authors:  R S Dick; H R Hubbell
Journal:  J Neurooncol       Date:  1987       Impact factor: 4.130

8.  Flow cytometric analysis of antineoplastic effects of interferon-alpha, beta and gamma labelled with fluorescein isothiocyanate on cultured brain tumors.

Authors:  Y Numa; K Kawamoto; N Sakai; H Matsumura
Journal:  J Neurooncol       Date:  1991-12       Impact factor: 4.130

Review 9.  The antitumor effects of interferon.

Authors:  I Gresser
Journal:  Med Oncol Tumor Pharmacother       Date:  1986

10.  Two phase II trials of temozolomide with interferon-alpha2b (pegylated and non-pegylated) in patients with recurrent glioblastoma multiforme.

Authors:  M D Groves; V K Puduvalli; M R Gilbert; V A Levin; C A Conrad; V H Liu; K Hunter; C Meyers; K R Hess; W K Alfred Yung
Journal:  Br J Cancer       Date:  2009-08-18       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.